Results 141 to 150 of about 54,719 (217)

Hemostasis and Type 1 Neurofibromatosis

Plastic and Reconstructive Surgery, Global Open, 2017
Jeremy Niddam, MD, Catherine Matheron, MD, Simone La Padula, MD, Pierre Wolkenstein, MD, PhD, Jean-paul Meningaud, MD, PhD   +4 more
doaj   +1 more source

LKB1–AMPK Signaling Pathway in Cardiovascular and Other Diseases

MedComm, Volume 7, Issue 3, March 2026.
The LKB1–AMPK pathway has a central regulatory role in various diseases. Dysfunction of this pathway can lead to pathological processes in cardiovascular diseases (atrial fibrillation, myocardial infarction, myocardial hypertrophy, atherosclerosis), metabolic diseases (diabetes and kidney disease), neurodegenerative diseases (Alzheimer's disease ...
Zhuo Chen, Qin Yang, Guo‐Wei He
wiley   +1 more source

Precision Oncology for Pediatric Solid Tumors Using In‐Hospital Pediatric/AYA Malignancy‐Specific Panel Sequencing

Cancer Science, Volume 117, Issue 3, Page 797-806, March 2026.
Our findings indicate that a pediatric/AYA‐specific targeted panel deployed in a hospital can deliver rapid, clinically actionable molecular insights with high diagnostic and prognostic yield. This complements larger sequencing platforms by offering speed, focused content, and easier interpretation.
Masato Kojima, Sho Kurihara, Isamu Saeki, Ryo Touge, Keigo Nakashima, Shuhei Karakawa, Fumiyuki Yamasaki, Satoshi Okada, Eiso Hiyama   +8 more
wiley   +1 more source

Merlin Phosphorylation by p21-activated Kinase 2 and Effects of Phosphorylation on Merlin Localization [PDF]

, 2002
The Nf2 tumor suppressor gene product merlin is related to the membrane-cytoskeleton linker proteins of the band 4.1 superfamily, including ezrin, radixin, and moesin (ERMs). Merlin is regulated by phosphorylation in a Rac/cdc42-dependent fashion.
Eckman, Matthew S., Jacks, Tyler, Johnson, Kristen C., Kissil, Joseph L.   +3 more
core   +1 more source

Giant gluteal and vesical plexiform neurofibromas in a patient with neurofibromatosis type 1: a case report

Journal of Medical Case Reports
Background Neurofibromatosis type 1 is a neurocutaneous genetic disorder caused by mutations in the NF1 gene, resulting in the formation of benign tumors called neurofibromas.
Imen Sassi, Mohamed Amine Bouida, Anis Hasnaoui, Ines Zemni, Tarek Ben Dhieb   +4 more
doaj   +1 more source

Neurofibromatosis type 1 with unusual oral manifestations

Journal of Indian Academy of Oral Medicine and Radiology, 2012
Neurofibromatosis (NF) is a genetically transmitted autosomal dominant disorder with variable penetrance and about 50% of cases representing new mutations.
Raghavendra Kini, Vathsala Naik, Ashwini Baliga, Anjali P Shetty, Y R Girish   +4 more
doaj  

Neurofibromatosis type 1 [PDF]

, 2020
Jordan J. Cole, Rosalie E. Ferner, David H. Gutmann   +2 more
openaire   +2 more sources

[Pheochromocytoma in Neurofibromatosis Type 1]. [PDF]

Probl Endokrinol (Mosk)
Rebrova DV, Loginova OI, Nepomnyashchaya SL, Bakhtiyarova AR, Rusakov VF, Krasnov LM, Fedorov EA, Chinchuk IK, Shikhmagomedov SS, Imyanitov EN, Kuleshov OV, Alekseev MA, Pridvijkina TS, Savelyeva TV, Semenov AA, Zgoda EA, Chernikov RA, Sleptsov IV.   +17 more
europepmc   +1 more source

Pathology in Practice [PDF]

, 2017
Lofts, R, Priestnall, S L, Summers, B A, Terry, R   +3 more
core   +1 more source

Neurofibromatosis type 1 with unilateral macrodactyly-like overgrowth: a case report. [PDF]

Case Reports Plast Surg Hand Surg
Klaus L, Hoh M, Beyersdorf B, Ruemmele D, Jallow ASH, Mtaita DG, Dolderer J.   +6 more
europepmc   +1 more source